Header Logo

Connection

CHARLES MINARD to Adolescent

Back to Details
This is a "connection" page, showing publications CHARLES MINARD has written about Adolescent.
CHARLES MINARD
Connection Strength
0.913
Adolescent
  1. Phase I Trial of Selinexor in Pediatric Recurrent/Refractory Solid and CNS Tumors (ADVL1414): A Children's Oncology Group Phase I Consortium Trial. Clin Cancer Res. 2025 May 01; 31(9):1587-1595.
    View in: PubMed
    Score: 0.017
  2. Age and sex mark clinical differences in the presentation of pediatric type 1 diabetes mellitus. J Pediatr Endocrinol Metab. 2025 Jan 29; 38(1):22-28.
    View in: PubMed
    Score: 0.017
  3. A Phase 1 Study of ABI-009 (Nab-sirolimus) in Combination With Temozolomide and Irinotecan in Pediatric Patients With Recurrent or Refractory Solid Tumors, Including CNS Tumors-A Children's Oncology Group Pediatric Early Phase Clinical Trial Network Study ADVL1514. Cancer Med. 2024 Nov; 13(21):e70376.
    View in: PubMed
    Score: 0.016
  4. DiaBetter Together: Clinical trial protocol for a strengths-based Peer Mentor intervention for young adults with type 1 diabetes transitioning to adult care. Contemp Clin Trials. 2024 Dec; 147:107713.
    View in: PubMed
    Score: 0.016
  5. Phase 1 study of NEDD8 activating enzyme inhibitor pevonedistat in combination with chemotherapy in pediatric patients with recurrent or refractory solid tumors (ADVL1615). Eur J Cancer. 2024 Sep; 209:114241.
    View in: PubMed
    Score: 0.016
  6. Diabetic ketoacidosis in youth with diabetes mellitus during the COVID-19 pandemic. J Pediatr Endocrinol Metab. 2024 Sep 25; 37(9):759-763.
    View in: PubMed
    Score: 0.016
  7. Unswitched memory B cell deficiency in children with sickle cell disease and response to pneumococcal polysaccharide vaccine. Am J Hematol. 2024 06; 99(6):1084-1094.
    View in: PubMed
    Score: 0.016
  8. A phase 1/2 study of pepinemab in children, adolescents, or young adults with recurrent or refractory solid tumors: A children's oncology group consortium report (ADVL1614). Pediatr Blood Cancer. 2024 Jun; 71(6):e30938.
    View in: PubMed
    Score: 0.016
  9. Elevated Serum IgA at Onset of Type 1 Diabetes in Children. Pediatr Diabetes. 2024; 2024:7284088.
    View in: PubMed
    Score: 0.016
  10. High Prevalence of A-?+ Ketosis-Prone Diabetes in Children with Type 2 Diabetes and Diabetic Ketoacidosis at Diagnosis: Evidence from the Rare and Atypical Diabetes Network (RADIANT). Pediatr Diabetes. 2024; 2024.
    View in: PubMed
    Score: 0.016
  11. A phase 1 trial utilizing a pharmacokinetic endpoint to determine the optimal dose of ramucirumab in children and adolescents with relapsed or refractory solid tumors, including central nervous system tumors. Pediatr Blood Cancer. 2024 Mar; 71(3):e30817.
    View in: PubMed
    Score: 0.016
  12. Social Determinant of Health Impact on Diabetes Device Use and Clinical Outcomes in Youth with Type 1 Diabetes. Pediatr Diabetes. 2023; 2023:4751595.
    View in: PubMed
    Score: 0.015
  13. Feasibility of pevonedistat combined with azacitidine, fludarabine, cytarabine in pediatric relapsed/refractory AML: Results from COG ADVL1712. Pediatr Blood Cancer. 2023 Dec; 70(12):e30672.
    View in: PubMed
    Score: 0.015
  14. Milder loss of insulin-containing islets in individuals with type 1 diabetes and type 2 diabetes-associated TCF7L2 genetic variants. Diabetologia. 2023 01; 66(1):127-131.
    View in: PubMed
    Score: 0.014
  15. Peer-support intervention for African American and Latino parents to improve the glycemic control trajectory among school-aged children with type 1 diabetes: A pilot and feasibility protocol. Contemp Clin Trials. 2022 05; 116:106739.
    View in: PubMed
    Score: 0.014
  16. Clinical application of home sleep apnea testing in children: a prospective pilot study. J Clin Sleep Med. 2022 Feb 01; 18(2):533-540.
    View in: PubMed
    Score: 0.014
  17. Whole-exome analysis of adolescents with low VWF and heavy menstrual bleeding identifies novel genetic associations. Blood Adv. 2022 01 25; 6(2):420-428.
    View in: PubMed
    Score: 0.014
  18. Maximum Dose Food Challenges Reveal Transient Sustained Unresponsiveness in Peanut Oral Immunotherapy (POIMD Study). J Allergy Clin Immunol Pract. 2022 02; 10(2):566-576.e6.
    View in: PubMed
    Score: 0.013
  19. Treatment age and neurocognitive outcomes following proton beam radiotherapy for pediatric low- and intermediate-grade gliomas. Pediatr Blood Cancer. 2021 08; 68(8):e29096.
    View in: PubMed
    Score: 0.013
  20. Health-related quality of life in parents and partners of people with type 1 diabetes: Development and validation of type 1 diabetes and life (T1DAL) measures. Fam Syst Health. 2021 06; 39(2):234-247.
    View in: PubMed
    Score: 0.013
  21. A phase 1 study of prexasertib (LY2606368), a CHK1/2 inhibitor, in pediatric patients with recurrent or refractory solid tumors, including CNS tumors: A report from the Children's Oncology Group Pediatric Early Phase Clinical Trials Network (ADVL1515). Pediatr Blood Cancer. 2021 09; 68(9):e29065.
    View in: PubMed
    Score: 0.013
  22. A phase 1 study of entinostat in children and adolescents with recurrent or refractory solid tumors, including CNS tumors: Trial ADVL1513, Pediatric Early Phase-Clinical Trial Network (PEP-CTN). Pediatr Blood Cancer. 2021 04; 68(4):e28892.
    View in: PubMed
    Score: 0.013
  23. Design and psychometrics for new measures of health-related quality of life in adults with type 1 diabetes: Type 1 Diabetes and Life (T1DAL). Diabetes Res Clin Pract. 2021 Apr; 174:108537.
    View in: PubMed
    Score: 0.013
  24. Safety, tolerability and pharmacokinetics of crizotinib in combination with cytotoxic chemotherapy for pediatric patients with refractory solid tumors or anaplastic large cell lymphoma (ALCL): a Children's Oncology Group phase 1 consortium study (ADVL1212). Cancer Chemother Pharmacol. 2020 12; 86(6):829-840.
    View in: PubMed
    Score: 0.012
  25. Diabetes distress and HbA1c in racially/ethnically and socioeconomically diverse youth with type 1 diabetes. Pediatr Diabetes. 2020 11; 21(7):1362-1369.
    View in: PubMed
    Score: 0.012
  26. Is high-risk neuroblastoma induction chemotherapy possible without G-CSF? A pilot study of safety and treatment delays in the absence of primary prophylactic hematopoietic growth factors. Pediatr Blood Cancer. 2020 10; 67(10):e28417.
    View in: PubMed
    Score: 0.012
  27. The spectrum and severity of bleeding in adolescents with low von Willebrand factor-associated heavy menstrual bleeding. Blood Adv. 2020 07 14; 4(13):3209-3216.
    View in: PubMed
    Score: 0.012
  28. Novel dose escalation to predict treatment with hydroxyurea (NDEPTH): A randomized controlled trial of a dose-prediction equation to determine maximum tolerated dose of hydroxyurea in pediatric sickle cell disease. Am J Hematol. 2020 09; 95(9):E242-E244.
    View in: PubMed
    Score: 0.012
  29. Type 1 Doing Well: Pilot Feasibility and Acceptability Study of a Strengths-Based mHealth App for Parents of Adolescents with Type 1 Diabetes. Diabetes Technol Ther. 2020 11; 22(11):835-845.
    View in: PubMed
    Score: 0.012
  30. Assessing Health-Related Quality of Life in Children and Adolescents with Diabetes: Development and Psychometrics of the Type 1 Diabetes and Life (T1DAL) Measures. J Pediatr Psychol. 2020 04 01; 45(3):328-339.
    View in: PubMed
    Score: 0.012
  31. Nivolumab in children and young adults with relapsed or refractory solid tumours or lymphoma (ADVL1412): a multicentre, open-label, single-arm, phase 1-2 trial. Lancet Oncol. 2020 04; 21(4):541-550.
    View in: PubMed
    Score: 0.012
  32. Phase I Clinical Trial of the Wee1 Inhibitor Adavosertib (AZD1775) with Irinotecan in Children with Relapsed Solid Tumors: A COG Phase I Consortium Report (ADVL1312). Clin Cancer Res. 2020 03 15; 26(6):1213-1219.
    View in: PubMed
    Score: 0.012
  33. Skin testing with different food formulations in pediatric patients with eosinophilic esophagitis. Pediatr Allergy Immunol. 2020 04; 31(3):329-332.
    View in: PubMed
    Score: 0.012
  34. Phase 1/2 trial of talazoparib in combination with temozolomide in children and adolescents with refractory/recurrent solid tumors including Ewing sarcoma: A Children's Oncology Group Phase 1 Consortium study (ADVL1411). Pediatr Blood Cancer. 2020 02; 67(2):e28073.
    View in: PubMed
    Score: 0.012
  35. IV Antibiotic Durations for Nontyphoidal Salmonella Bacteremia. Hosp Pediatr. 2019 12; 9(12):993-997.
    View in: PubMed
    Score: 0.012
  36. Cardiopulmonary Resuscitation in the Pediatric Cardiac Catheterization Laboratory: A Report From the American Heart Association's Get With the Guidelines-Resuscitation Registry. Pediatr Crit Care Med. 2019 11; 20(11):1040-1047.
    View in: PubMed
    Score: 0.012
  37. Prospective, longitudinal comparison of neurocognitive change in pediatric brain tumor patients treated with proton radiotherapy versus surgery only. Neuro Oncol. 2019 06 10; 21(6):809-818.
    View in: PubMed
    Score: 0.011
  38. Challenges in the Contemporary Management of Syphilis among Pregnant Women in New Orleans, LA. Infect Dis Obstet Gynecol. 2019; 2019:2613962.
    View in: PubMed
    Score: 0.011
  39. NK cells in treated HIV-infected children display altered phenotype and function. J Allergy Clin Immunol. 2019 07; 144(1):294-303.e13.
    View in: PubMed
    Score: 0.011
  40. Two-year evolution of latent rheumatic heart disease in Malawi. Congenit Heart Dis. 2019 Jul; 14(4):614-618.
    View in: PubMed
    Score: 0.011
  41. Reducing pediatric asthma hospital length of stay through evidence-based quality improvement and deployment of computerized provider order entry. J Asthma. 2020 02; 57(2):123-135.
    View in: PubMed
    Score: 0.011
  42. Featured Article: Strengths-Based, Clinic-Integrated Nonrandomized Pilot Intervention to Promote Type 1 Diabetes Adherence and Well-Being. J Pediatr Psychol. 2019 01 01; 44(1):5-15.
    View in: PubMed
    Score: 0.011
  43. A study of axitinib, a VEGF receptor tyrosine kinase inhibitor, in children and adolescents with recurrent or refractory solid tumors: A Children's Oncology Group phase 1 and pilot consortium trial (ADVL1315). Cancer. 2018 12 01; 124(23):4548-4555.
    View in: PubMed
    Score: 0.011
  44. Pediatric continuous renal replacement therapy: have practice changes changed outcomes? A large single-center ten-year retrospective evaluation. BMC Nephrol. 2018 10 19; 19(1):268.
    View in: PubMed
    Score: 0.011
  45. Outcomes in Children Treated with Pentobarbital Infusion for Refractory and Super-Refractory Status Epilepticus. Neurocrit Care. 2018 10; 29(2):171-179.
    View in: PubMed
    Score: 0.011
  46. A phase 1 study of eribulin mesylate (E7389), a novel microtubule-targeting chemotherapeutic agent, in children with refractory or recurrent solid tumors: A Children's Oncology Group Phase 1 Consortium study (ADVL1314). Pediatr Blood Cancer. 2018 08; 65(8):e27066.
    View in: PubMed
    Score: 0.011
  47. A phase 1 study of cabozantinib in children and adolescents with recurrent or refractory solid tumors, including CNS tumors: Trial ADVL1211, a report from the Children's Oncology Group. Pediatr Blood Cancer. 2018 08; 65(8):e27077.
    View in: PubMed
    Score: 0.010
  48. Phase 1 trial of ontuxizumab (MORAb-004) in children with relapsed or refractory solid tumors: A report from the Children's Oncology Group Phase 1 Pilot Consortium (ADVL1213). Pediatr Blood Cancer. 2018 05; 65(5):e26944.
    View in: PubMed
    Score: 0.010
  49. Quality of life for parents of children with food allergy in peanut-restricted versus peanut-free schools in the United States and Canada. J Allergy Clin Immunol Pract. 2018 Mar - Apr; 6(2):671-673.e7.
    View in: PubMed
    Score: 0.010
  50. Multicenter prevalence of anaphylaxis in clinic-based oral food challenges. Ann Allergy Asthma Immunol. 2017 10; 119(4):339-348.e1.
    View in: PubMed
    Score: 0.010
  51. Correlating Resting-State Functional Magnetic Resonance Imaging Connectivity by Independent Component Analysis-Based Epileptogenic Zones with Intracranial Electroencephalogram Localized Seizure Onset Zones and Surgical Outcomes in Prospective Pediatric Intractable Epilepsy Study. Brain Connect. 2017 09; 7(7):424-442.
    View in: PubMed
    Score: 0.010
  52. Rapid infusion of rituximab is well tolerated in children with hematologic, oncologic, and rheumatologic disorders. Pediatr Blood Cancer. 2018 Jan; 65(1).
    View in: PubMed
    Score: 0.010
  53. Targeting ALK With Crizotinib in Pediatric Anaplastic Large Cell Lymphoma and Inflammatory Myofibroblastic Tumor: A Children's Oncology Group Study. J Clin Oncol. 2017 Oct 01; 35(28):3215-3221.
    View in: PubMed
    Score: 0.010
  54. Prevalence of Vaccine Hesitancy Among Expectant Mothers in Houston, Texas. Acad Pediatr. 2018 03; 18(2):154-160.
    View in: PubMed
    Score: 0.010
  55. High-resolution phenotyping identifies NK cell subsets that distinguish healthy children from adults. PLoS One. 2017; 12(8):e0181134.
    View in: PubMed
    Score: 0.010
  56. Pediatric Phase I Trial and Pharmacokinetic Study of Trebananib in Relapsed Solid Tumors, Including Primary Tumors of the Central Nervous System ADVL1115: A Children's Oncology Group Phase I Consortium Report. Clin Cancer Res. 2017 Oct 15; 23(20):6062-6069.
    View in: PubMed
    Score: 0.010
  57. HIV-infected Children in Malawi Have Decreased Performance on the 6-minute Walk Test With Preserved Cardiac Mechanics Regardless of Antiretroviral Treatment Status. Pediatr Infect Dis J. 2017 07; 36(7):659-664.
    View in: PubMed
    Score: 0.010
  58. Combination Steroid and Test-based Food Elimination for Eosinophilic Esophagitis: A Retrospective Analysis. J Pediatr Gastroenterol Nutr. 2017 06; 64(6):933-938.
    View in: PubMed
    Score: 0.010
  59. A phase 1 study of the c-Met inhibitor, tivantinib (ARQ197) in children with relapsed or refractory solid tumors: A Children's Oncology Group study phase 1 and pilot consortium trial (ADVL1111). Pediatr Blood Cancer. 2017 Nov; 64(11).
    View in: PubMed
    Score: 0.010
  60. A phase 1 trial of temsirolimus and intensive re-induction chemotherapy for 2nd or greater relapse of acute lymphoblastic leukaemia: a Children's Oncology Group study (ADVL1114). Br J Haematol. 2017 05; 177(3):467-474.
    View in: PubMed
    Score: 0.010
  61. A decade of pediatric tracheostomies: Indications, outcomes, and long-term prognosis. Pediatr Pulmonol. 2017 07; 52(7):946-953.
    View in: PubMed
    Score: 0.010
  62. Increased Incidence of Fatigue in Patients with Primary Immunodeficiency Disorders: Prevalence and Associations Within the US Immunodeficiency Network Registry. J Clin Immunol. 2017 Feb; 37(2):153-165.
    View in: PubMed
    Score: 0.010
  63. First-dose and steady-state pharmacokinetics of orally administered crizotinib in children with solid tumors: a report on ADVL0912 from the Children's Oncology Group Phase 1/Pilot Consortium. Cancer Chemother Pharmacol. 2017 Jan; 79(1):181-187.
    View in: PubMed
    Score: 0.010
  64. Task shifting to clinical officer-led echocardiography screening for detecting rheumatic heart disease in Malawi, Africa. Cardiol Young. 2017 Aug; 27(6):1133-1139.
    View in: PubMed
    Score: 0.010
  65. Brief Report: Further Examination of Self-Injurious Behaviors in Children and Adolescents with Autism Spectrum Disorders. J Autism Dev Disord. 2016 May; 46(5):1872-9.
    View in: PubMed
    Score: 0.009
  66. School and Community Screening Shows Malawi, Africa, to Have a High Prevalence of Latent Rheumatic Heart Disease. Congenit Heart Dis. 2016 Dec; 11(6):615-621.
    View in: PubMed
    Score: 0.009
  67. The complex behavioral phenotype of 15q13.3 microdeletion syndrome. Genet Med. 2016 11; 18(11):1111-1118.
    View in: PubMed
    Score: 0.009
  68. Parental report of vaccine receipt in children with autism spectrum disorder: Do rates differ by pattern of ASD onset? Vaccine. 2016 Mar 08; 34(11):1335-42.
    View in: PubMed
    Score: 0.009
  69. Comparing Intelligence Quotient Change After Treatment With Proton Versus Photon Radiation Therapy for Pediatric Brain Tumors. J Clin Oncol. 2016 Apr 01; 34(10):1043-9.
    View in: PubMed
    Score: 0.009
  70. Outcomes of two-drug maintenance immunosuppression for pediatric renal transplantation: 10-yr follow-up in a single center. Pediatr Transplant. 2016 Feb; 20(1):49-58.
    View in: PubMed
    Score: 0.009
  71. An Examination of Physician-, Caregiver-, and Disease-Related Factors Associated With Readmission From a Pediatric Hospital Medicine Service. Hosp Pediatr. 2015 Nov; 5(11):566-73.
    View in: PubMed
    Score: 0.009
  72. Aspartate aminotransferase to platelet ratio and fibrosis-4 as biomarkers in biopsy-validated pediatric cystic fibrosis liver disease. Hepatology. 2015 Nov; 62(5):1576-83.
    View in: PubMed
    Score: 0.009
  73. Risk factors in pediatric shrimp allergy. Allergy Asthma Proc. 2015 Jul-Aug; 36(4):65-71.
    View in: PubMed
    Score: 0.009
  74. Pregnancy outcomes in advanced kidney disease. Clin Nephrol. 2015 May; 83(5):272-8.
    View in: PubMed
    Score: 0.009
  75. High titer anti-basement membrane antibodies in a subset of patients with pediatric systemic lupus erythematosus. Am J Nephrol. 2015; 41(3):241-7.
    View in: PubMed
    Score: 0.009
  76. Early and 1-year outcomes of aortic root surgery in patients with Marfan syndrome: a prospective, multicenter, comparative study. J Thorac Cardiovasc Surg. 2014 Jun; 147(6):1758-66, 1767.e1-4.
    View in: PubMed
    Score: 0.008
  77. Randomized trial of "bleach baths" plus routine hygienic measures vs. routine hygienic measures alone for prevention of recurrent infections. Clin Infect Dis. 2014 Mar; 58(5):679-82.
    View in: PubMed
    Score: 0.008
  78. Health-related quality of life functioning over a 2-year period in children with end-stage renal disease. Pediatr Nephrol. 2013 Feb; 28(2):285-93.
    View in: PubMed
    Score: 0.007
  79. Staphylococcus aureus infections in pediatric patients with diabetes mellitus. J Infect. 2012 Aug; 65(2):135-41.
    View in: PubMed
    Score: 0.007
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.